We test the solubility of this product at 10 mg/mL in a 0.1 M phosphate buffer (pH 6.0). In regards to solution stability of this product, the following information has been listed under Preparation Note on the product's webpage: Solutions of this product at 1 mg/mL in 0.1 M phosphate buffer (pH 6.0) remain active for at least two weeks at room temperature. The solution retains activity after 5 freeze-thaw cycles.
Przejdź do
Wybierz wielkość
| Rozmiar/SKU | Dostępność | Cena netto |
|---|---|---|
5 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 395,00 zł |
10 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 826,00 zł |
25 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 1230,00 zł |
50 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 1900,00 zł |
100 mg | Skontaktuj się z Obsługą Klienta, aby uzyskać informacje na temat dostępności | 3650,00 zł |
Informacje o tej pozycji
395,00 zł
type
Type VI-A
Quality Segment
form
essentially salt-free, lyophilized powder
specific activity
≥250 units/mg solid (using pyrogallol), 950-2000 units/mg solid (using ABTS)
mol wt
~44 kDa
solubility
0.1 M phosphate buffer: soluble 10 mg/mL, clear, orange to red (pH 6.0), H2O: soluble
application(s)
diagnostic assay manufacturing
storage temp.
2-8°C
SMILES string
[O+H2]O[O-]
InChI
1S/H2O3/c1-3-2/h1-2H
InChI key
JSPLKZUTYZBBKA-UHFFFAOYSA-N
General description
Application
Biochem/physiol Actions
Packaging
Preparation Note
Analysis Note
Other Notes
1 of 1
Ta pozycja | |||
|---|---|---|---|
| description Type VI-A, essentially salt-free, lyophilized powder, 950-2000 units/mg solid (using ABTS), ≥250 units/mg solid (using pyrogallol) | description Type II, essentially salt-free, lyophilized powder, 150-250 units/mg solid (using pyrogallol) | description Type XII, essentially salt-free, lyophilized powder, ≥250 units/mg solid (using pyrogallol) | description For research or further manufacturing use only. Not intended for direct use in humans or animals. Non-TSCA use only in US, Type VI, powder, stabilized, ≥250 units/mg solid (using pyrogallol) |
| specific activity ≥250 units/mg solid (using pyrogallol), 950-2000 units/mg solid (using ABTS) | specific activity 150-250 units/mg solid (using pyrogallol) | specific activity ≥250 units/mg solid (using pyrogallol) | specific activity ≥250 units/mg solid (using pyrogallol) |
| application(s) diagnostic assay manufacturing | application(s) diagnostic assay manufacturing | application(s) - | application(s) diagnostic assay manufacturing |
| form essentially salt-free, lyophilized powder | form essentially salt-free, lyophilized powder | form essentially salt-free, lyophilized powder | form powder, stabilized |
| mol wt ~44 kDa | mol wt ~44 kDa | mol wt ~44 kDa | mol wt - |
| solubility 0.1 M phosphate buffer: soluble 10 mg/mL, clear, orange to red (pH 6.0), H2O: soluble | solubility 0.1 M phosphate buffer: soluble (pH 6.0), H2O: soluble | solubility 0.1 M phosphate buffer: soluble (pH 6.0), H2O: soluble | solubility phosphate buffer: soluble |
| storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C | storage temp. 2-8°C |
Still not finding the right product?
Explore all of our products under Peroxidase from horseradish
signalword
Danger
hcodes
pcodes
Hazard Classifications
Resp. Sens. 1
Klasa składowania
11 - Combustible Solids
ppe
Eyeshields, Gloves, type N95 (US)
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.
-
Can I dissolve 10mg HRP powder by splitting into certain concentrations like 1mg/ml,4mg/ml and 5mg/ml by weighing 1mg,4mg and 5mg amount and dissolving it separately instead of made it to 10mg/ml in phosphate buffer as mention catalog. Will it work?
1 answer-
Helpful?
-




